Budget 2026: Experts Urge Public Spending Boost and GST Relief on Lifesaving Equipment and Vaccines

As the Union Budget 2026-27 approaches, industry experts have called on the Indian government to significantly increase public health spending and introduce GST exemptions on lifesaving medical equipment and vaccines. This appeal comes amid growing concerns about the affordability and accessibility of critical healthcare resources, particularly for patients suffering from chronic conditions such as thalassemia and cancer. Experts argue that enhanced government investment in health infrastructure and financial relief through tax exemptions can alleviate the burden on patients and improve overall public health outcomes.

The demand for GST relief targets essential medical devices and vaccines that are often prohibitively expensive due to taxation. By exempting these items from the Goods and Services Tax, the government could reduce costs for patients and healthcare providers alike, making treatments more accessible. This is especially crucial for diseases like thalassemia, which requires regular blood transfusions and costly supportive care, and cancer, where treatment expenses can be overwhelming. Industry voices emphasize that such fiscal measures would not only benefit patients but also stimulate the healthcare sector by encouraging innovation and production of affordable medical technologies.

Increasing public health expenditure is another key recommendation from experts. They highlight that current spending levels are insufficient to meet the growing healthcare demands of India's vast population. Enhanced funding could support the expansion of healthcare infrastructure, improve the quality and reach of medical services, and strengthen preventive care programs. This is particularly important in rural and underserved areas where access to quality healthcare remains a challenge. Experts suggest that a strategic allocation of budgetary resources towards health can lead to long-term economic benefits by reducing disease burden and improving workforce productivity.

The calls for budgetary reforms reflect a broader recognition of health as a critical component of national development. With the ongoing challenges posed by non-communicable diseases and the need for robust pandemic preparedness, experts believe that proactive government intervention is essential. The proposed GST exemptions and increased spending are seen as pragmatic steps to enhance healthcare affordability and infrastructure. If implemented, these measures could set a precedent for prioritizing health in fiscal policy, ultimately contributing to a healthier and more resilient population.

In summary, the upcoming Union Budget 2026-27 presents an opportunity for the government to address pressing healthcare challenges through targeted financial policies. Industry experts advocate for a dual approach: boosting public health expenditure and granting GST relief on lifesaving medical equipment and vaccines. Such initiatives would not only ease the financial strain on patients but also strengthen the healthcare ecosystem, fostering innovation and equitable access. As the budget unfolds, stakeholders will be closely watching for measures that align with these expert recommendations to support India's health sector growth and public welfare.